Here's the live share price of Cipla along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Cipla has gained 15.44% CAGR. Over the past year, the corresponding return has been 2.00%.
Cipla’s current P/E of 22.72x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Breakout Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cipla | 1.71 | -1.47 | -2.15 | 2.33 | 2.00 | 10.66 | 15.44 |
| Sun Pharmaceutical Industries | 3.76 | 6.19 | 6.93 | 2.83 | -0.69 | 20.00 | 27.86 |
| Divi's Laboratories | -2.05 | -0.60 | 6.36 | 5.14 | 13.50 | 25.77 | 13.60 |
| Torrent Pharmaceuticals | 7.46 | 9.30 | 6.20 | 18.61 | 23.99 | 32.64 | 23.06 |
| Dr. Reddy's Laboratories | 3.29 | 0.62 | -1.14 | 2.06 | 1.54 | 12.55 | 5.02 |
| Zydus Lifesciences | 0.02 | -3.59 | -4.54 | 4.42 | -1.47 | 30.57 | 17.06 |
| Lupin | 4.24 | 6.06 | 4.86 | -0.82 | 2.07 | 39.35 | 17.79 |
| Mankind Pharma | 0.21 | -6.89 | -8.27 | -11.10 | -12.97 | 16.78 | 9.75 |
| Aurobindo Pharma | 9.35 | 9.30 | 13.39 | 0.68 | -1.63 | 36.07 | 7.57 |
| Alkem Laboratories | 0.40 | 3.68 | 6.58 | 11.12 | 3.16 | 21.85 | 16.03 |
| Abbott India | 1.66 | -2.73 | -11.90 | -3.52 | 7.07 | 13.63 | 13.43 |
| Biocon | 8.12 | 16.84 | 14.37 | 21.62 | 22.30 | 12.79 | -1.08 |
| Laurus Labs | 1.56 | 13.84 | 16.12 | 64.66 | 105.42 | 28.63 | 28.06 |
| Glenmark Pharmaceuticals | 4.24 | -0.10 | -7.43 | 31.09 | 23.52 | 63.78 | 31.26 |
| GlaxoSmithKline Pharmaceuticals | -4.35 | -10.32 | -10.50 | -13.88 | 0.86 | 22.86 | 11.42 |
| Anthem Biosciences | -2.60 | -12.11 | -17.80 | -7.05 | -7.05 | -2.41 | -1.45 |
| Ipca Laboratories | 13.07 | 14.57 | 9.26 | 5.32 | -2.76 | 19.74 | 7.37 |
| Ajanta Pharma | -0.03 | 5.54 | -5.88 | -2.45 | -11.72 | 26.01 | 19.60 |
| Gland Pharma | -1.66 | -4.63 | -7.31 | 25.28 | 3.30 | 1.77 | 0.10 |
| J B Chemicals & Pharmaceuticals | 7.21 | 10.09 | 6.42 | 13.28 | 8.00 | 22.61 | 30.39 |
Over the last one year, Cipla has gained 2.00% compared to peers like Sun Pharmaceutical Industries (-0.69%), Divi's Laboratories (13.50%), Torrent Pharmaceuticals (23.99%). From a 5 year perspective, Cipla has outperformed peers relative to Sun Pharmaceutical Industries (27.86%) and Divi's Laboratories (13.60%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,510.59 | 1,519.09 |
| 10 | 1,519.1 | 1,524.77 |
| 20 | 1,556.72 | 1,535.95 |
| 50 | 1,548.16 | 1,541.61 |
| 100 | 1,533.4 | 1,533.86 |
| 200 | 1,505.11 | 1,517.96 |
In the latest quarter, Cipla saw a rise in promoter holding to 29.22%, while DII stake increased to 30.25%, FII holding fell to 24.54%, and public shareholding moved down to 15.99% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,10,00,000 | 3.69 | 3,156.93 | |
| 99,88,840 | 1.25 | 1,501.62 | |
| 60,98,542 | 3.01 | 916.79 | |
| 60,00,000 | 3.83 | 901.98 | |
| 54,00,000 | 4.88 | 811.78 | |
| 38,36,985 | 1.22 | 576.81 | |
| 35,50,000 | 0.99 | 533.67 | |
| 35,00,000 | 4.28 | 526.16 | |
| 34,95,054 | 6.48 | 525.41 | |
| 29,00,000 | 0.83 | 435.96 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Nov 03, 2025, 10:08 PM IST | Cipla - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 03, 2025, 9:12 PM IST | Cipla - Announcement under Regulation 30 (LODR)-Acquisition |
| Oct 31, 2025, 12:06 AM IST | Cipla - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 30, 2025, 7:28 PM IST | Cipla - Outcome Of Board Meeting Dated 30Th October, 2025 |
| Oct 30, 2025, 7:22 PM IST | Cipla - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 19044.85 Cr. and Equity Capital is Rs. 161.52 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cipla is ₹1,530.20 as on Nov 14, 2025.
The Cipla is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Cipla is ₹123,605.15 Cr as on Nov 14, 2025.
Today’s highest and lowest price of Cipla are ₹1,534.60 and ₹1,523.00.
The 52-week high/low is the highest and lowest price at which Cipla stock has traded in the past 52-week or nearly a year. The 52-week high of Cipla is ₹1,672.20 and 52-week low of Cipla is ₹1,310.05 as on Nov 14, 2025.
The Cipla has shown returns of 0.29% over the past day, -1.47% for the past month, -2.15% over 3 months, 2.0% over 1 year, 10.66% across 3 years, and 15.44% over 5 years.
P/E ratio of and PB ratio of Cipla are 22.72 and 3.96 on Nov 14, 2025. While the company gives a dividend yield of 1.05 per annum.